New transplant prep shows promise for tough blood cancers
NCT ID NCT00534430
First seen Jun 03, 2026 · Last updated Jun 16, 2026 · Updated 3 times
Summary
This study tested a combination of chemotherapy (busulfan and etoposide) and low-dose total body radiation before a donor bone marrow transplant in 30 people with advanced leukemia or myelodysplastic syndromes. The goal was to see how well this approach helped patients survive cancer-free for five years. Participants also received drugs to prevent graft-versus-host disease, a common complication where donor cells attack the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.